Cidara Therapeutics (CDTX) PT Raised at RBC Capital; 'Would Be Buyers Into Strength'
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams raised the price target on Cidara Therapeutics (NASDAQ: CDTX) to $75.00 (from $35.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
